CRISPR/Cas9 technology generated an AAG to GCA change resulting in a lysine to alanine mutation at amino acid 525 (K525A). This mutation abolishes ATP-dependent helicase activity. (J:277473)
查看原文 参与反馈
CRISPR/Cas9 technology generated an AAG to GCA change resulting in a lysine to alanine mutation at amino acid 525 (K525A). This mutation abolishes ATP-dependent helicase activity. (J:277473)